| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/13/2009 | CN100486580C 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
| 05/13/2009 | CN100486569C Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 05/13/2009 | CN100486567C Curcumin emulsion and its preparation process |
| 05/13/2009 | CN100486560C Slow released compound anticancer injection containing blood vessel inhibitor |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531648 Gene therapy |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 05/12/2009 | US7531604 Phospholipid derivative containing a polyoxyalkylene group comprising two or more kinds of alkylene oxides, as well as a surfactant, solubilizer, dispersing agent; for cosmetics and lipid membrane structures; drug delivery of antitumor agents |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531539 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531530 derivatives of tricyclic lactam indoles and tricyclic lactam benzimidazoles; poly (ADP-ribose) polymerase (PARP) inhibitors; breast cancer, cancers caused by genetic defect in a gene; side effects reduction by not administering as a combination therapy; low doses; antiapoptosis; BRCA1 or BRCA2 expression |
| 05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531506 Process for producing trunkamide a compounds |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
| 05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
| 05/12/2009 | US7531162 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation |
| 05/12/2009 | CA2548078C Pharmaceutical formulations of camptothecins and process for making same |
| 05/12/2009 | CA2517933C Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors |
| 05/12/2009 | CA2415749C Method of producing infectious reovirus |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/12/2009 | CA2303448C Specific steady-state r-type ca2+ channel blockers and use thereof |
| 05/07/2009 | WO2009059309A2 Furin-cleavable peptide linkers for drug-ligand conjugates |
| 05/07/2009 | WO2009059201A2 Id2 as a target in colorectal carcinoma |
| 05/07/2009 | WO2009058907A2 Targeting micrornas for the treatment of liver cancer |
| 05/07/2009 | WO2009058801A1 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer |
| 05/07/2009 | WO2009058739A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 05/07/2009 | WO2009058730A1 Diamido thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | WO2009058728A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | WO2009058394A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 05/07/2009 | WO2009058267A2 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | WO2009058102A1 Methods and compounds for preventing and treating a tumour |
| 05/07/2009 | WO2009057795A2 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 05/07/2009 | WO2009057763A1 Novel adjuvant |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057139A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056886A1 Pyrimidine derivatives and their use as modulators of fgfr activity |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056671A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | WO2009056660A1 Novel chemotherapeutic agents for cancer treatment |
| 05/07/2009 | WO2009056556A1 Substitute 1, 6-naphthyridines for use as scd inhibitors |
| 05/07/2009 | WO2009056434A1 Combination products for treating cancer |
| 05/07/2009 | WO2009056256A1 Use of megestrol acetate having improved solubility for the treatment of cancer cachexia |
| 05/07/2009 | WO2009056029A1 Purification method of pemetrexed salts,sodium salts and disodium salts |
| 05/07/2009 | WO2009055937A1 Altered n-cadherin processing in tumor cells by furln and proproteln convertase 5a (pc5a) |
| 05/07/2009 | WO2009055907A1 Apoptin induces inhibition of bcr-abl kinase in cml cells |
| 05/07/2009 | WO2009037001A3 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 05/07/2009 | WO2009036753A3 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009032256A3 Apc activators in combination with a cytokine-secreting cell and methods of use thereof |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2009017701A3 Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 05/07/2009 | WO2009017463A3 NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE |
| 05/07/2009 | WO2009010789A3 Pyrimidine derivatives 934 |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008157179A3 N-substituted azaindoles and methods of use |
| 05/07/2009 | WO2008153730A3 Method for treating proliferative disorders associated with mutations in c-met |
| 05/07/2009 | WO2008122858A3 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 05/07/2009 | WO2008095040A3 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents |
| 05/07/2009 | WO2008076278A3 Methods of cancer treatment with igf1r inhibitors |
| 05/07/2009 | WO2008074749A9 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 05/07/2009 | WO2007067364A3 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 05/07/2009 | US20090118377 Apogossypolone and the uses thereof |
| 05/07/2009 | US20090118373 Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
| 05/07/2009 | US20090118370 Method of treating cancer using dichloroacetate |
| 05/07/2009 | US20090118362 Chemotherapeutic agents for inhibition of protein translation |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118357 Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| 05/07/2009 | US20090118356 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 05/07/2009 | US20090118355 Fluorotaxoids |
| 05/07/2009 | US20090118344 Crystalline Chemotherapeutic |
| 05/07/2009 | US20090118340 Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers |
| 05/07/2009 | US20090118332 Therapeutic Agents - 551 |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118324 Mapk/erk kinase inhibitors |
| 05/07/2009 | US20090118323 Antitumor benzoylsulfonamides |
| 05/07/2009 | US20090118321 5-Urea Substituted Naphthalimide Derivatives, Methods of Production and Pharmaceutical Compositions for Treating Cancer |
| 05/07/2009 | US20090118311 DHFR Enzyme Inhibitors |
| 05/07/2009 | US20090118310 Activated Cdc42-associated kinase (ACK) as a therapeutic target for Ras-induced cancer |
| 05/07/2009 | US20090118305 Pyridine and pyrazine derivatives - 083 |